Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Muslim nations condemn new Israeli death penalty law - 2A definitive Manual for Internet Mastering and Expertise Improvement
- 3What's going on with Katseye? The Manon Bannerman hiatus drama, explained.
- 4Hostile to Maturing Skincare Items to Rejuvenate Your Skin
- 5Spain breaks jobs record with 22 million Social Security contributors
- Doomed SpaceX Starlink satellite photographed from orbit
- Surveys of Thrillers That Re-imagined the Class
- April full moon 2026 dazzles as 'Pink Moon' lights up skies worldwide (photos)
- Nestlé recalls infant formula in 49 countries. See list.
- Map shows more than 1,900 measles cases across U.S.
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
- Bother Control Administrations for 2024: Decide for Your Home
- Iran warns its ready to open new front in Yemen, close Bab al-Mandab Strait with Houthis
